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Cellular/Molecular
A Molecular Circuit Composed of CPEB-1 and c-Jun Controls
Growth Hormone-Mediated Synaptic Plasticity in the
Mouse Hippocampus
N. Ruth Zearfoss,1 JuanMarcos Alarcon,2 Pierre Trifilieff,2 Eric Kandel,2,3 and Joel D. Richter1
1Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01605, 2College of Physicians and Surgeons of
Columbia University, and 3Howard Hughes Medical Institute, Center for Neurobiology and Behavior, Columbia University, New York, New York 10032
Cytoplasmic polyadenylation element binding protein 1 (CPEB-1) resides at postsynaptic sites in hippocampal neurons in which it
controls polyadenylation-induced translation. CPEB-1 knock-out (KO) mice display defects in some forms of synaptic plasticity and
hippocampal-dependent memories. To identify CPEB-1-regulated mRNAs, we used proteomics to compare polypeptides in wild-type
(WT) and CPEB-1 KO hippocampus. Growth hormone (GH) was reduced in the KO hippocampus, as were the GH signaling molecules
phospho-JAK2 and phospho-STAT3. GHmRNA and pre-mRNA were reduced in the KO hippocampus, suggesting that CPEB-1 controls
GH transcription. The transcription factor c-Jun, which binds the GH promoter, was also reduced in the KO hippocampus, as was its
ability to coimmunoprecipitate chromatin containing the GH promoter. CPEB-1 binds c-Jun 3 untranslated region CPEs in vitro and
coimmunoprecipitates c-Jun RNA in vivo. GH induces long-term potentiation (LTP) when applied to hippocampal slices fromWT and
CPEB-1 KOmice, but the magnitude of LTP induced by GH in KOmice is reduced. Pretreatment with GH did not reverse the LTP deficit
observed in KOmice after theta-burst stimulation (TBS). Cordycepin, an inhibitor of polyadenylation, disrupted LTP induced by either
GH application or TBS. Finally, GH application to hippocampal slices induced JAK2 phosphorylation in WT but not KO animals. These
results indicate that CPEB-1 control of c-JunmRNA translation regulates GHgene expression and resulting downstream signaling events
(e.g., synaptic plasticity) in the mouse hippocampus.
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Introduction
Experience-induced alterations in synaptic connections (synap-
tic plasticity) are thought to underlie learning and memory (Kan-
del, 2001). Activity-dependent protein synthesis promotes these
alterations (Steward and Schuman, 2003; Sutton and Schuman,
2005), which could involve the recruitment of mRNAs onto poly-
somes. One mechanism that regulates mRNA translation in the
synapto-dendritic compartment involves the cytoplasmic poly-
adenylation element binding protein (CPEB-1), a sequence-
specific RNA binding protein (Mendez and Richter, 2001; Theis
et al., 2003; Huang et al., 2006) that interacts with the cytoplasmic
polyadenylation element (CPE), a U-rich structure in the 3 un-
translated regions (UTRs) of certain mRNAs. Once phosphory-
lated, CPEB-1 stimulates polyadenylation and translation (Men-
dez et al., 2000; Barnard et al., 2004; Kim and Richter, 2006; Kim
and Richter, 2007); in synapto-dendrites, CPEB-1 phosphoryla-
tion is mediated by NMDA receptor activation (Wu et al., 1998;
Huang et al., 2002; Atkins et al., 2004).
Analysis of CPEB-1 knock-out (KO) mice supports a role for
this protein in certain types of synaptic plasticity and learning and
memory. Theta-burst stimulation (TBS) of Schaffer collateral
CA1 hippocampal neurons results in a decrease in long-term
potentiation (LTP). Moreover, hippocampal long-term depres-
sion elicited by 1 Hz stimulation is more enduring in the KO mice
compared with wild type (WT) (Alarcon et al., 2004). CPEB-1
KO mice also have alterations in hippocampus-dependent be-
havioral tasks (Berger-Sweeney et al., 2006), which together with
some of the electrophysiological parameters noted above may
require protein synthesis (Berman and Dudai, 2001; Vianna et al.,
2001; Pedreira and Maldonado, 2003; Santini et al., 2004).
We used two-dimensional gel electrophoresis and mass spec-
trometry to identify proteins with altered abundance levels in the
hippocampus of CPEB-1 KO versus WT mice. Growth hormone
(GH) was the most dramatically changed; it was reduced by10-
fold in the KO hippocampus. GH modulates synaptic efficacy of
hippocampal neurons and itself is regulated during memory for-
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mation (Donahue et al., 2002, 2006; Mahmoud and Grover,
2006). GH can signal through janus kinase 2 (JAK2) phospho-
Y1007/Y1008 and signal transducer and activator of transcription
3 (STAT3) phospho-Y205 (Zhu et al., 2001), both of which were
reduced in the KO hippocampus. GH mRNA and pre-mRNA
were also reduced, suggesting that GH transcription is directly or
indirectly regulated by CPEB-1. The mouse GH promoter con-
tains binding sites for c-Jun whose mRNA contains CPEs that are
bound by CPEB. c-Jun levels were reduced in the KO hippocam-
pus, as was its ability to coimmunoprecipitate chromatin con-
taining the GH promoter. GH stimulated LTP in hippocampal
slices from WT and KO mice, although LTP expression in the KO
was reduced. LTP expression was also altered when the slices were
incubated with cordycepin, which inhibits polyadenylation.
These data suggest that c-Jun mRNA translation is regulated by
CPEB-1 and that GH transcription via c-Jun could be partially
responsible for the changes in synaptic plasticity and behavior in
the CPEB-1 KO mouse. Moreover, GH stimulation of LTP may
involve cytoplasmic polyadenylation; this polypeptide may thus
act in autocrine and paracrine manner to stimulate CPEB-1
activity.
Materials andMethods
Animals, cell culture, and biochemistry. CPEB-1 KO mice (Tay and Rich-
ter, 2001) were backcrossed onto the C57BL/6 background for four to
nine generations. The brain was removed from males only and chilled on
ice, and the hippocampus was manually dissected from the surrounding
tissues and snap frozen in liquid nitrogen until use. Hippocampal protein
was extracted as described by Davis et al. (2006), separated on two-
dimensional gels, and stained with SYPRO-Ruby. Spots were determined
to be significantly different as assessed by Progenesis Discover and Pro
software (Nonlinear Dynamics). Normalized spot volume was deter-
mined by principle component analysis; pairwise comparisons of spots
between WT and CPEB-1 KO hippocampus were performed with the
Student’s t test in the Progenesis Discovery software (Davis et al., 2006).
Selected spots were excised, and their identity was determined by mass
spectrometry. All proteomics were conducted by the University of Mas-
sachusetts Medical School Proteomics facility. For Western blotting, pro-
tein extracts were prepared according to Cao et al. (2005), or, for hip-
pocampal slices, flash-frozen tissue was disrupted by sonication in 1%
SDS or directly in sample buffer. CPEB-1 antibody has been described by
Tay et al. (2003) or purchased from Affinity Bioreagents; c-Jun antibody
was a gift from Roger Davis (University of Massachusetts Medical
School, Worcester, MA) or was purchased from Cell Signaling
Technologies.
RNA was extracted from hippocampal tissue using Trizol (Invitrogen)
and treated with RQ1 RNase-free DNase (Promega). cDNA was ampli-
fied with Taq polymerase (Qiagen) in a reaction mix that contained 10
mM dATP, dGTP, and dTTP but 0.2 mM dCTP as well as trace amounts of
[- 32P]dCTP. For each primer pair, the optimal cycle number was em-
pirically determined. Primer sequences were as follows: c-Jun, 5-
CCTTCTACGACGATGCCCTCAA-3 and 5-GGGGTCGGTGTAGT-
GGTGATGT-3; GH, 5-CTGGCTGCTGACACCTACAAAG-3 and 5-
TGTTGGTGAAAATCCTGCTGAG-3; GH intron, 5- GGGCAGG-
AGTATGGGGTAGGAC-3 and 5-TTTCTCCTGCCCTCCTGTCTCT-
3; neurofilament (NF), 5-CCTCAAGTCTATCCGCACACAA-3 and
5-TGCTTCTCGTTAGTGGCGTCTT-3. The PCR products were sep-
arated on denaturing polyacrylamide gels.
Chromatin immunoprecipitation (ChIP) from hippocampal tissue
was performed as described previously (Chen-Plotkin et al., 2006). Two
hippocampal pairs were pooled for each genotype. Genomic DNA coim-
munoprecipitating with c-Jun was identified by PCR with the following
primers: c-Jun sites 1 and 2 in the GH promoter, 5-GAGGAGGAA-
CAATAGGAGGAA-3 and 5- TCTGTCTCTTTGTCTGTCCATC-3;
c-Jun site 3 in the GH promoter, 5-GCAAACATGGCT-
GGCTCACTCT-3 and 5-TCTTTTTGGACCCTGGAGTTCT-3; GH
intron, 5- GGGCAGGAGTATGGGGTAGGAC-3 and 5-TTTCTC-
CTGCCCTCCTGTCTCT-3; glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH) exon, 5-GCTAAGGCTACACAGACAAACTC-3 and
5-AGGAGCAGAGAGCCAGTTTGTTA-3.
RNA–protein coimmunoprecipitation was modified from the proce-
dure of Tenenbaum et al. (2000, 2002). Hippocampal tissue from
CPEB-1 KO and WT littermates was rinsed with ice-cold PBS and ho-
mogenized in lysis buffer containing 10 mM HEPES, pH 7.4, 100 mM KCl,
5 mM MgCl2, 0.5% NP-40, 1 mM DTT, 3 l/ml RNase inhibitor (RNA-
guard), 0.2% vanadyl ribonucleoside complex, 10 l/ml of 10 mM phe-
nylmethylsulfonyl fluoride, and 10l of a 10 mg/ml stock of pepstatin A,
aprotinin, and leupeptin. One hundred microliters of this extract was
diluted with 400 l of NT2 (50 mM Tris, pH 7.4, 150 mM KCl, 1 mM
MgCl2, plus the RNase and protease inhibitors noted above). Five micro-
grams of antibody was added, and the reaction was mixed end-over-end
overnight at 4°C. Twenty microliters of Dynabeads M-280 were washed
with NT2 supplemented with 5% BSA and 0.05% NP-40 and then added
to the extract, which was incubated with tumbling for 4 h at 4°C. The
beads were then washed five times with NT2 supplemented with 0.05%
NP-40, and the protein was digested with 0.1% SDS and 0.3 mg/ml
proteinase K. The RNA was then phenol extracted and subjected to re-
verse transcription (RT)-PCR as described above. The RNA gel shift was
conducted according to Hake et al. (1998) using an in vitro transcribed
region of the c-Jun 3 UTR that contains the CPEs.
Electrophysiology. Transverse hippocampal slices (400m) from wild-
type and CPEB-1 KO mice (2.5– 4 months old) were incubated at room
temperature with oxygenated artificial CSF (ACSF) (in mM: 119 NaCl, 4
KCI, 1.5 MgSO4, 2.5 CaCI2, 26.2 NaHCO3, 1 NaH2PO4, and 11 glucose)
and allowed to equilibrate for 60 min. The slices were then placed in a
submerged chamber with ACSF at 28  1°C for at least 30 min before
recording. Field EPSPs (fEPSPs) were recorded at CA3–CA1 synapses via
stimulation of the Schaffer collateral axons with a bipolar electrode
CBAPD75 (FHC) and recording with a 4 –5 M glass pipette (A-M
Systems). The stimulation intensity (square pulse, 50 s duration) was
adjusted to give fEPSP slopes of40% of maximum. Baseline and post-
stimulation responses were sampled once per minute at this intensity.
The LTP protocol for theta-burst stimulation was a single theta-burst
episode, which consisted of nine bursts of four pulses at 100 Hz with 200
ms interburst intervals.
For some experiments, to ensure that a large portion of hippocampal
slice CA1 neurons be subjected to TBS treatment, the stimulating and
recording electrodes were positioned at the beginning (CA2/CA1 bor-
der) and the ending (CA1/subiculum border) of the CA1 area, respec-
tively. For all experiments, two slices from approximately the same hip-
pocampal area were recorded in parallel, one control and one stimulated.
At the end of the recordings, slices were collected and immediately frozen
on dry ice. The CA1 area was the dissected out under a microscope and
stored at 80°C. For GH-treated material, hippocampal slices were in-
cubated at room temperature in ACSF and allowed to equilibrate for 90
min before GH application (22 ng/ml). Slices were collected at the indi-
cated times (slices from WT and KO mice were treated in parallel), frozen
on dry ice, and stored at80°C.
Statistics. Statistical analysis for the electrophysiology was performed
using a two-tailed two-population Student’s t test (Microcal Origin sta-
tistical tool). Data are reported as mean  SE in the figures and as
mean SD in the text. The experimentaln equals the number of animals;
at least two slices were recorded per animal.
Drugs. Recombinant human growth hormone (Cell Sciences), recon-
stituted in water at 100 g/ml, was bath applied onto the slices (at 22
ng/ml) for the times indicated in each experiment. Cordycepin (3-
deoxyadenosine) (Sigma) was dissolved in 50% ethanol for a final con-
centration of 200 g/ml to bathe slices (2% ethanol). Control experi-
ments were performed in ACSF plus 2% ethanol. The pretreatment
process (30 min) was performed to ensure an optimal effect of the drug in
slices.
Results
Growth hormone is deficient in the CPEB-1 KO hippocampus
CPEB-1 KO mice have defects in some types of synaptic plasticity
(Alarcon et al., 2004) and hippocampal-dependent memories
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such as extinction (Berger-Sweeney et al., 2006). To identify mo-
lecular targets of CPEB-1 that could be responsible, at least in
part, for these phenotypes, total hippocampal protein from WT
and CPEB-1 KO male littermates was resolved by two-
dimensional PAGE using two different isoelectric point ranges
and stained with SYPRO-Ruby (Fig. 1A). The protein gels, ana-
lyzed in triplicate, were scanned, and the relative amount of signal
in each spot was quantified. One protein that was consistently
lower in the KO hippocampus by10-fold (Fig. 1A) was excised
and identified by mass spectrometry to be GH (also referred to as
somatotropin). Two other proteins were consistently altered in
the KO hippocampus: b crystalline (lower by approximately
fivefold), and collapsin response mediator protein 3 (CRMP3)
(increased by approximately twofold). Because the importance of
b crystalline and CRMP3 for neuronal activities is unknown, we
focused on GH, which has been reported to influence synaptic
activity (Mahmoud and Grover, 2006). Although the primary site
of GH synthesis is the pituitary, an analysis of that tissue revealed
that the level of GH was not changed in the KO (data not shown).
GH signals to cells by interacting with and causing the dimer-
ization and phosphorylation of its trans-membrane receptor,
which then activates a JAK/STAT signaling cascade. Although
GH can activate a number of JAKs and STATs, the cascade can
involve the phosphorylation of JAK2 Y1007/1008 and the phos-
phorylation of STAT3 Y-205 (Zhu et al., 2001). Phospho-STAT3
then homodimerizes or heterodimerizes and is transported to the
nucleus in which it stimulates transcription (Fig. 1B) (Moutous-
samy et al., 1998; Herrington and Carter-Su, 2001). To determine
whether GH-dependent signaling is altered in the KO mouse, we
examined several tyrosine-phosphorylated JAKs and STATs. Al-
though we could detect no change in JAK1 phospho-Y1022/1023,
STAT3 phospho-Y5727, or STAT5 phospho-Y694 (data not
shown), we found that STAT3 phospho-Y205 and JAK2 phos-
pho-Y1007/1008 were reduced in the hippocampus of KO versus
WT animals (Fig. 1C). Finally, we determined whether one
downstream target gene of STAT3 that has been shown to be GH
responsive (Liao et al., 1997), Fos, was also reduced in the
CPEB-1 KO hippocampus. Compared with NF RNA as a control,
Figure 1. Growth hormone expression and signaling is reduced in the CPEB-1 KOmouse hippocampus. A, Representative SYPRO-Ruby-stained two-dimensional gel and the detection of a spot
that was reduced10-fold in the KO hippocampus. Mass spectrometry identified this spot as GH. Gels were analyzed in triplicate using tissue from one pair ofWT and KO littermates.B, Schematic
diagramofGH signaling. GHbinds transmembrane receptors,which,whenautophosphorylated, induce the activation of the kinase JAK2byphosphorylating residues of Y1007 andY1008. JAK2 then
phosphorylates Y205 of STAT3, which causes it to homodimerize or heterodimerize and be translocated to the nucleus in which it binds DNA and stimulates transcription. C, Hippocampal extracts
from WT and CPEB-1 KO mice were immunoblotted and probed for STAT3 and JAK2, as well as for phospho-Y205 of STAT3, phospho-Y1007 and phospho-Y1008 of JAK2, and tubulin (Tub).
Representative blots are shown of an analysis of at least two pairs of animals.D, RNA fromWT and CPEB-1 KO hippocampus was subjected to semiquantitative RT-PCR for Fos and NF RNAs. A serial
twofold dilution of input RNA fromWT hippocampus is shown in lanes 1–4 (Std). In some cases, the RT step was omitted and served as a negative control. Three replicates of this experiment were
performedusingRNA from three different age-matchedWTandKOpairs, and the differences in the Fos signal betweenWTandKOhippocampuswere statistically significant ( p0.025, one-tailed
paired-sample t test).
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Fos RNA levels were reduced by a modest 30% in the hippocampus
of unstimulated animals; although this amount was variable, it was
statistically significant ( p 0.025, one-tailed paired sample t test)
(Fig. 1D). Because Fos is an immediate early gene whose transcrip-
tion increases substantially on certain types of synaptic stimulation,
we also examined the relative levels of Fos RNA in the hippocampus
of animals injected with kainate, a seizure-causing agent (Theis et al.,
2003). Although Fos levels increased 10-fold after kainate treat-
ment, there was no discernable difference between WT and KO an-
imals (data not shown). Thus, although CPEB-1 influences the basal
level of Fos RNA, it has no effect on the amount of this mRNA after
synaptic stimulation and seizure.
GHmRNA and pre-mRNA are reduced in the CPEB-1
KO hippocampus
Although the primary site of GH gene expression is the pituitary,
it is also synthesized in the hippocampus (Donahue et al., 2006).
To determine whether CPEB-1 might affect GH RNA levels, total
RNA from the hippocampus of WT and CPEB-1 KO mice was
subjected to semiquantitative RT-PCR using exon-specific GH
primers. GH mRNA, like the protein, was reduced in the hip-
pocampus of the CPEB-1 KO mouse. NF RNA levels were the
same in WT and KO hippocampus (Fig. 2A).
Because the GH 3 UTR contains no obvious CPE, we rea-
soned that the reduction of GH mRNA in the KO hippocampus
might be a secondary effect and that factors affecting GH RNA
synthesis or stability could be direct targets of CPEB-1 activity. To
assess this possibility, primers specific for introns 1 and 2 of GH
pre-mRNA were used for semiquantitative RT-PCR. Like GH
protein and mRNA, GH pre-mRNA was also reduced in the KO
hippocampus. As before, NF RNA was the same in WT and KO
hippocampus (Fig. 2B). These results suggest that GH gene tran-
scription is inhibited in the CPEB-1 KO hippocampus, leading us
to speculate that CPEB-1 might control the expression of a factor
that in turn controls GH transcription.
c-Jun levels are reduced in the CPEB-1 KO hippocampus
We examined the GH promoter for binding sites of transcription
factors whose mRNAs contain CPEs. One primary candidate was
Pit-1, which controls GH transcription in the pituitary. Although
Pit-1 RNA contains CPEs, we could detect no Pit-1 mRNA or
protein in the hippocampus (data not shown). Another tran-
scription factor we considered was c-Jun. The GH promoter con-
tains two c-Jun consensus binding sites
(TGAGTCA) located3.9 and 4.3 kb up-
stream of the start of transcription; a third
nonconsensus site (TGAGTTCA) is 0.5
kb upstream of the start of transcription
(Fig. 3A). The two consensus c-Jun sites
also reside near putative nuclear factor of
activated T-cells (NFAT) transcription
factor binding sites; NFAT and AP-1 (i.e.,
c-Jun homodimers or c-Jun/Fos het-
erodimers) are thought to cooperate in
promoting transcription (Macian et al.,
2001). Moreover, the mRNA encoding
c-Jun contains CPEs (Fig. 3B). Most im-
portantly, the hippocampus contains
c-Jun protein in relative abundance, which
was reduced by 50% in the CPEB-1 KO
mouse (Fig. 3C). To investigate whether
the GH promoter is bound by c-Jun, we
performed ChIP experiments using an an-
tibody specific for c-Jun protein. WT and CPEB-1 KO hippocam-
pus were treated with formaldehyde to covalently crosslink chro-
matin proteins to DNA; the DNA was then sonicated to an
average length of 0.5 kb (0.2–1 kb), followed by c-Jun immuno-
precipitation, crosslink reversal, and PCR detection of specific
DNA sequences. Figure 3D shows that, in the WT hippocampus,
c-Jun antibody immunoprecipitated DNA in the GH promoter
that contains the two c-Jun consensus sites; this did not occur in
the CPEB-1 KO hippocampus. The c-Jun antibody did not im-
munoprecipitate DNA containing the nonconsensus c-Jun site in
the GH promoter (c-Jun 3), a GH intron, or a GAPDH exon;
these latter two sequences served as negative controls. Moreover,
a nonspecific antibody against a hemagglutinin epitope did not
immunoprecipitate any of the DNA sequences from WT or KO
hippocampus. These data demonstrate that c-Jun binds the GH
promoter and may control GH transcription.
To determine whether c-Jun RNA could be a direct target of
CPEB-1 regulation, ribonucleoproteins from WT and CPEB-1
KO hippocampus were subjected to CPEB-1 antibody coimmu-
noprecipitation, followed by semiquantitative RT-PCR for c-Jun
and NF RNAs. c-Jun RNA was coimmunoprecipitated with
CPEB-1 from WT but not KO hippocampus (Fig. 3D, left). Only
background levels of NF were coimmunoprecipitated from WT
and KO hippocampus. In the absence of reverse transcriptase, no
c-Jun or NF amplification products were detected from WT or
KO hippocampus (Fig. 3D, right). Finally, a gel shift assay shows
that the c-Jun 3UTR was bound by recombinant CPEB-1 in vitro
but not when CPE-containing RNA was added to the gel shift
mixture (Fig. 3E). Thus, in the wild-type hippocampus, CPEB-1
control of c-Jun mRNA translation results in GH transcription.
GH-induced LTP is deficient in CPEB-1 KO mice
As reported previously by others, bath application of GH to hip-
pocampal slices produced a robust LTP in Schaffer collateral to CA1
pyramidal neuronal synapses of WT mice (Mahmoud and Grover,
2006). However, the same treatment in slices from KO animals pro-
duced LTP with a reduction of40% (Fig. 4A,B; note the 90–120
min time interval; WT, 170  18%; KO, 139  15%; p  0.01),
suggesting that LTP expression in response to GH-signaling activa-
tion depends partially on CPEB function. To further explore the
nature of this deficiency, we next investigated the effect of GH pre-
treatment on LTP induced by TBS. We showed previously that TBS-
induced LTP is deficient in CPEB-1 KO mice (Alarcon et al., 2004)
Figure 2. Reduced GH RNA and pre-mRNA in the CPEB-1 KO hippocampus. A, RNA fromWT and CPEB-1 KO hippocampus was
subjected to semiquantitative RT-PCR with exon-specific primers for GH and NF RNAs. Input consisted of a serial twofold dilution
of RNA from the WT hippocampus. In some cases, the RT step was omitted. B, RNA from WT and CPEB-1 KO hippocampus was
subjected to semiquantitativeRT-PCRwith intron-specific primers for GHandNFRNAs. Standard (Std) consistedof a serial twofold
dilution of RNA from the WT hippocampus. In some cases, the RT step was omitted.
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and corroborated these early findings here (Fig. 4C1; TBS, 90–120
min time interval; WT, 158  15%; KO, 116  6%; p  0.0004).
Pretreatment of hippocampal slices with GH lessened the subse-
quent expression of LTP induced by TBS in WT mice (Fig. 4C2;
90–120 min time interval; WT, 119  14%), suggesting that both
GH-LTP and TBS-LTP share common expression mechanisms.
Most interestingly, GH pretreatment did not affect the subsequent
LTP induced by TBS in KO mice (Fig. 4C2; 90–120 min time inter-
val; 121  16%). This LTP was similar in magnitude to both the
occluded TBS-LTP in WT mice (Fig. 4C2; WT vs KO, p 0.88) and
the deficient TBS-LTP observed in KO mice without GH pretreat-
ment (Fig. 4C1, KO vs C2, KO; p  0.55). These results suggest a
connection between the deficient LTP induced by TBS in KO mice,
the reduced LTP induced by TBS in WT mice after GH treatment,
and the reduced LTP induced by bath application of GH in KO mice:
that is, an ablated GH-signaling pathway linked to CPEB-1 function.
To further investigate the connection between CPEB-1 function
and the LTP deficits associated with GH cascade activation, we used
the polyadenylation blocker cordycepin (3-deoxyadenosine). Be-
cause of the 3-deoxy moiety, this nucleoside analog acts by blocking
poly(A) elongation. Pretreatment with cordycepin dramatically af-
fected both types of LTP, TBS-LTP (Fig. 4D1; 90–120 min time
interval; control, 168  13%; cordycepin, 138  16%; p 0.037)
and GH-LTP (Fig. 4D2; 90–120 min time interval; control, 176
14%; cordycepin, 148 9%;p 0.008), indicating that polyadenyl-
ation is a critical process for the expression of each form of LTP.
Finally, we prepared hippocampal slices to investigate whether
TBS or GH could stimulate elements of the GH signaling cascade. In
the dissected, stimulated CA1, TBS did induce the expression of
c-Jun (Fig. 5A), although we could not detect signals with the
phospho-JAK2 or phospho-STAT3 antibodies because of their rela-
tively low abundance and the small size of the tissue sample. When
GH was applied to slices, we observed an increase in phospho-JAK2
with no change in the level of JAK2. Moreover, this increase was not
observed in the CPEB-1 KO hippocampus (Fig. 5B). Unfortunately,
we could not reliably detect a phospho-STAT3 signal in these slices.
Nonetheless, these data show that GH signaling in the hippocampus
requires CPEB-1.
Discussion
Our two-dimensional gels revealed that, compared with WT hip-
pocampus, three proteins were changed in the KO: GH and b
crystalline were decreased (10-fold and5-fold, respectively),
whereas CRMP3 was increased (2-fold). Although GH produc-
tion is often associated with the pituitary, it is also synthesized in
the hippocampus (Sun et al., 2005; Donahue et al., 2006), and
indeed we detected GH mRNA and pre-mRNA in that tissue. GH
RNA and pre-mRNA were reduced in the KO hippocampus, and
Figure 3. CPEB-1 regulates c-Jun RNA translation.A, Illustration of the GH gene showing two consensus c-Jun sites (4 kb upstreamof the start of transcription) and a third nonconsensus c-Jun
site (0.5 kbupstream). Theprimers used for PCR todetect various regions ofDNAare indicated.Hippocampus from twoWTor CPEB-1KOanimalswas subjected to aChIP assaywith c-Junantibody.
After formaldehyde-induced DNA–protein crosslinking and sonication to shear the DNA, c-Jun was immunoprecipitated (IP), the crosslinks were reversed, and the DNA was subjected to PCR with
primers specific for c-Jun sites 1 and 2, c-Jun site 3, a GH intron, and a GAPDH exon. HA, Hemagglutinin.B, Relevant sequence of the c-Jun 3UTR. The putative CPEs and the AAUAAAhexanucleotide
arenoted.C, Immunoblot of c-JunandNF fromhippocampal extracts derived fromWTandCPEB-1KOhippocampus.A representativeblot is shown fromananalysis of twopairs of animals.D, Extracts
derived fromWTandCPEB-1KOhippocampusweresubjectedto immunoprecipitationwithCPEB-1antibody, followedbyRNAextractionandsemiquantitativeRT-PCRfor c-JunandNFRNAs.Tenpercentof the
inputmaterial, before immunoprecipitation, is also shown. Extracts fromWThippocampuswas also immunoprecipitatedwith anonspecific IgG,which served as an additional negative control. Standard (Std)
consisted of a serial twofold dilution of RNA from theWThippocampus. The right panel shows relative c-JunRNA levels in the absence of immunoprecipitation fromWTandCPEB-1KOhippocampuswhen the
RTstepwasbothincludedandomitted.E,RNAgelshiftofthec-Jun3UTRwithCPEB-1.RecombinantCPEB-1wasmixedwith 32P-labledc-Jun3UTRand, in lanes3and4,withexcessunlabeledCPE-containing
or CPE-lacking RNA,whichwas followedby electrophoresis in a nondenaturing gel. The RNA–protein complex (shifted RNA) and free RNAare noted.
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molecules downstream of the GH receptor, phospho-JAK2 and
phospho-SAT3, were also reduced. These results suggested that
an mRNA encoding a transcription factor that controls GH ex-
pression might be directly regulated by CPEB-1. The GH pro-
moter contains several transcription factor binding sites, and the
mRNA encoding c-Jun harbors CPEs. On immunoblots, c-Jun
was reduced by approximately twofold in the KO versus WT
hippocampus. Sequences containing c-Jun sites in the GH pro-
moter were coimmunoprecipitated with c-Jun from WT but not
KO hippocampus. c-Jun RNA was bound by CPEB-1 and coim-
munoprecipitated with it from WT but
not KO hippocampus. These data suggest
that CPEB-1 regulation of c-Jun mRNA
translation controls downstream events
that culminate in changes in synaptic plas-
ticity and hippocampal-dependent
memories.
GH plays a role in neural function be-
cause dwarf mice with pituitary GH defi-
ciencies are resistant to the cognitive de-
cline that is commonly associated with
aging (Kinney et al., 2001; Kinney-Forshee
et al., 2004). Recent data suggests that GH
directly affects synaptic efficacy; for exam-
ple, Mahmoud and Grover (2006) exam-
ined synaptic transmission in CA1 syn-
apses in the presence or absence of GH and
observed an enhancement of NMDA- and
AMPA-dependent synaptic responses.
Additionally, upregulation of GH expres-
sion is observed after learning (Donahue et
al., 2006). Given that GH is produced in
the hippocampus, we speculate that it op-
erates in an autocrine manner as well as
communicating with neighboring cells.
Thus, GH secretion could increase the ef-
ficacy of synaptic transmission among
cells in their immediate environment.
The reduction in c-Jun and phospho-
STAT3 in the KO hippocampus might be
expected to result in reduced expression of
many genes. However, our proteomics
analysis as well as an investigation using
microarrays to detect changed RNA levels
in the WT and KO hippocampus revealed
few alterations of more than twofold
(Berger-Sweeney et al., 2006). Although
there might be several low-abundance
mRNAs whose levels change substantially
in the KO hippocampus, it seems more
likely that GH represents one of the few
genes whose expression is profoundly af-
fected by the loss of CPEB-1. Although the
loss of GH probably contributes to the
electrophysiological and behavioral phe-
notypes observed in the KO mouse, it is
unlikely to be solely responsible for them;
modest changes in the expression of other
genes in the KO hippocampus may also
contribute. Moreover, because stimuli
that elicit LTP and long-term depression
induce the synthesis of many of the same
proteins (Kelleher et al., 2004), it has been
argued that the productive capture or utilization of proteins at
synapses, rather than their selective synthesis, controls synaptic
strength (Govindarajan et al., 2006).
Mahmoud and Grover (2006) demonstrated that GH induced
a form of LTP in hippocampal slices. We have extended these
results to show that GH does not do so in the presence of cordyce-
pin, an inhibitor of polyadenylation. Although we have not dem-
onstrated that GH induces polyadenylation, these results imply
that it does and that this process is necessary to establish LTP.
Figure 4. Analysis of GH-induced LTP.A, Illustration of the hippocampalmouse slice preparation andmicrograph showing the
placement of the stimulating (se) and recording (re) electrodes in the stratum radiatum (SR) of area CA1. DG, Dentate gyrus. B,
Bath application of recombinant human GH (22 ng/ml) onto slices elicits LTP in wild-type and CPEB-1 KO mice. Note that, at
90–120min, the amplitude of the LTP in KOanimals is 55%of that in thewild-type animals (n5 each forwild type andKO).C1,
TBS (arrow) induces a deficient LTP in KOmice (90–120min interval; n 4 each forwild type and KO). C2, Pretreatmentwith GH
fails to rescue deficient LTP in KO mice. The inset shows the complete experiment: after GH-induced LTP reached a plateau, the
stimulation strengthof the test pulseswas lowered tobaseline levels (*); 30min later, LTPwas inducedwith TBS (arrow) (90–120
min interval;n4 each forwild type andKO).D1, LTP inducedby TBS is dramatically impairedbypretreatment (30min)with the
polyadenylation blocker cordycepin (90–120 min interval, 200g/ml; n 5 each for control and cordycepin). D2, Cordycepin
pretreatment also impairs LTP induced by GH (90–120 min interval; n 5 each for control and cordycepin).
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Similarly, we provide evidence on the nature of the deficit in
electrically induced LTP by theta-burst stimulation observed in
the KO, namely, that of an altered GH signaling cascade.
The results presented here raise three additional issues, one of
which is the mechanism by which CPEB-1 controls c-Jun mRNA
translation. A likely possibility is cytoplasmic polyadenylation
because CPEB-1 controls this process in germ cells and the brain
(Richter, 2001; Klann and Richter, 2006). We have attempted to
determine whether the c-Jun poly(A) tail is altered in WT versus
KO hippocampus but have detected no change. However, c-Jun
RNA has multiple AAUAA motifs, indicating that there may be
multiple 3UTRs; if such is the case, our attempts to detect cyto-
plasmic polyadenylation would have been obscured (supplemen-
tal Fig. 1, available at www.jneurosci.org as supplemental mate-
rial). Moreover, perhaps only a small amount of c-Jun RNA is
regulated by CPEB-1, in which case changes in poly(A) would be
masked by the c-Jun that is not bound by CPEB-1. Finally, there
may be some indirect effects of CPEB-1 on c-Jun expression that
do not involve changes in poly(A). This possibility leads to the
second issue, which is the subcellular location of CPEB-1-
dependent regulation of c-Jun RNA. Although CPEB-1 resides at
synapses and in the cell body (Wu et al., 1998), we were particu-
larly interested to determine whether c-Jun RNA might be regu-
lated at synapses, in which CPEB-1 controls CaMKII mRNA
(Huang et al., 2002). Unfortunately, we were unable to observe a
c-Jun RNA signal in dendrites. However, we did detect c-Jun
protein in dendrites by immunostaining, but it usually did not
colocalize with synaptophysin, a synaptic marker (data not
shown). One intriguing possibility is that c-Jun is transported to
the nucleus after synthesis in the synapto-dendritic compart-
ment. It is noteworthy that the transcription factor NF-B (Mef-
fert et al., 2003) and proteins that mediate nuclear import, im-
portin  and , are transported from dendrite to nucleus in an
activity-dependent manner (Thompson et al., 2004).
Finally, the two transcription factors that are regulated by
CPEB-1, c-Jun (directly) and c-Fos (indirectly), are products of
immediate early genes that heterodimerize to form the transcrip-
tion factor AP-1. AP-1 controls the expression of genes in the
hippocampus, including TIMP-1, which modifies synaptic plas-
ticity (Kaczmarek et al., 2002). Thus, the expression of several
genes that are dependent on CPEB-1-controlled translation of
c-Jun mRNA could comprise a circuit of factors that modify
synaptic plasticity. Indeed c-Fos, as well as CPEB-1, has been
linked to memory extinction (Santini et al., 2004).
Figure 6 presents a speculative model that incorporates several of
the observations reported here into the overall context of CPEB-
mediated plasticity. CPEB controls the translation of c-Jun mRNA
translation in neurons, at least some of which might occur in the
synapto-dendritic compartment. This locally synthesized c-Jun
could then be transported to the nucleus in which, probably in con-
cert with other factors, it binds the GH promoter to induce the
transcription of this gene. GH mRNA would then likely be translated
in the cell body; GH would be secreted from the cell in which it could
stimulate plasticity of its own synapses (autocrine) and synapses of
neighboring cells (paracrine). However, GH-induced plasticity re-
quires CPEB, as demonstrated by the data in Figures 4 and 5. Because
GH has been shown to modulate NMDA receptor expression (Le
Greves et al., 2006), changes in postsynaptic NMDA receptors may
accompany GH activity. Additionally, Mahmoud and Grover
(2006) show that GH-induced LTP is mediated by both NMDA and
AMPA receptors. Thus, we speculate that a molecular circuit includ-
ing CPEB, c-Jun, and GH comprises a positive feedback loop that
mediates synaptic plasticity. This model also provides a framework
for future studies addressing cytoplasmic polyadenylation and pro-
tein synthesis-dependent synaptic plasticity.
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Figure 6. Model for CPEB-1-dependentmolecular circuitry in neurons. CPEB-1 in the synapto-dendritic compartment controls
local c-Jun mRNA translation (1, 2). c-Jun protein is then transported to the nucleus, in which it activates the transcription of GH
and perhaps other genes as well (3). Secreted GH interacts with receptors on the same cell and nearby cells in which it modifies
plasticity and other signaling events (4). Activation of GH receptors triggers transcription (5) and possibly polyadenylation byway
of CPEB-1. Newly formed NMDA and AMPA receptors maintain LTP (6).
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